A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

Miranda E. Orr(Washington University in St. Louis), Becky Powers(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Anis Larbi(Singapore Immunology Network), Nicolas Musi(Cedars-Sinai Medical Center), Darcy Bair‐Kelps(Geriatric Research Education and Clinical Center), Bess Frost(Allen Institute for Brain Science), Eithan Kotkowski(The University of Texas at San Antonio Health Science Center), Charles Brenner(City Of Hope National Medical Center), Paulino Ramirez(The University of Texas at San Antonio Health Science Center), Glenn Wong(University of California, Los Angeles), Sara Espinoza(Cedars-Sinai Medical Center), Qianqian Liu(The University of Texas at San Antonio Health Science Center), Peter T. Fox(The University of Texas at San Antonio Health Science Center), Crystal Tan(Agency for Science, Technology and Research), Mark S. Schmidt(University of Iowa)
GeroScience
November 23, 2023
Cited by 42


Related Papers